|
JRKL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6251444634463E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.60176341476881E-12 |
| Normal-vs-Stage2 |
4.30860003231004E-09 |
| Normal-vs-Stage3 |
6.16173778666962E-14 |
| Normal-vs-Stage4 |
1.25230048553249E-10 |
| Stage1-vs-Stage2 |
1.800200E-01 |
| Stage1-vs-Stage3 |
1.789990E-02 |
| Stage1-vs-Stage4 |
6.800100E-02 |
| Stage2-vs-Stage3 |
7.087400E-01 |
| Stage2-vs-Stage4 |
7.212200E-01 |
| Stage3-vs-Stage4 |
9.800000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.77395900588817E-15 |
| Normal-vs-AfricanAmerican |
2.370600E-04 |
| Normal-vs-Asian |
2.84009999995671E-06 |
| Caucasian-vs-AfricanAmerican |
3.914000E-01 |
| Caucasian-vs-Asian |
2.108800E-01 |
| AfricanAmerican-vs-Asian |
9.479200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.83804099612917E-13 |
| Normal-vs-Female |
1.63735691671718E-12 |
| Male-vs-Female |
4.759800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.09389966371521E-10 |
| Normal-vs-Age(41-60Yrs) |
1.0458300891969E-13 |
| Normal-vs-Age(61-80Yrs) |
1.88971061021448E-12 |
| Normal-vs-Age(81-100Yrs) |
1.200660E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.032500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.103000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.127980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.447000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.130200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.615800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.446080E-02 |
| Classical-VS-Follicular |
1.136770E-03 |
| Classical-VS-Other |
6.938400E-01 |
| Classical-VS-Normal |
2.65509999541891E-08 |
| Tall-VS-Follicular |
7.828400E-01 |
| Tall-VS-Other |
6.955000E-01 |
| Tall-VS-Normal |
5.0685000640982E-10 |
| Follicular-VS-Other |
5.274400E-01 |
| Follicular-VS-Normal |
2.5569546480142E-12 |
| Other-VS-Normal |
1.171750E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.3988810110277E-14 |
| Normal-vs-N1 |
6.74480005180556E-09 |
| N0-vs-N1 |
8.855000E-01 |
|
|
